# Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH)

> **NCT03526588** · PHASE1 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 3 (actual)

## Conditions studied

- Congenital Diaphragmatic Hernia

## Interventions

- **BIOLOGICAL:** Autologous umbilical cord blood

## Key facts

- **NCT ID:** NCT03526588
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-01
- **Primary completion:** 2022-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Competing randomized trial of an experimental therapy limited initial enrollment. The trial was completed, published, and the experimental therapy became broadly desired. Given this, the investigators felt it best to terminate this competing study.
- **Last updated:** 2024-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526588, "Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03526588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*